Literature DB >> 21550344

How do immune cells overcome the blood-brain barrier in multiple sclerosis?

Catherine Larochelle1, Jorge Ivan Alvarez, Alexandre Prat.   

Abstract

The presence of the blood-brain barrier (BBB) restricts the movement of soluble mediators and leukocytes from the periphery to the central nervous system (CNS). Leukocyte entry into the CNS is nonetheless an early event in multiple sclerosis (MS), an inflammatory disorder of the CNS. Whether BBB dysfunction precedes immune cell infiltration or is the consequence of perivascular leukocyte accumulation remains enigmatic, but leukocyte migration modifies BBB permeability. Immune cells of MS subjects express inflammatory cytokines, reactive oxygen species (ROS) and enzymes that can facilitate their migration to the CNS by influencing BBB function, either directly or indirectly. In this review, we describe how immune cells from the peripheral blood overcome the BBB and promote CNS inflammation in MS through BBB disruption.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550344     DOI: 10.1016/j.febslet.2011.04.066

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  123 in total

Review 1.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Factors controlling permeability of the blood-brain barrier.

Authors:  Mohammed M A Almutairi; Chen Gong; Yuexian G Xu; Yanzhong Chang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

Review 3.  Glial regulation of the blood-brain barrier in health and disease.

Authors:  Bieke Broux; Elizabeth Gowing; Alexandre Prat
Journal:  Semin Immunopathol       Date:  2015-08-06       Impact factor: 9.623

Review 4.  Immune-mediated processes in neurodegeneration: where do we stand?

Authors:  Marc Fakhoury
Journal:  J Neurol       Date:  2016-02-12       Impact factor: 4.849

5.  Endothelial-specific Crif1 deletion induces BBB maturation and disruption via the alteration of actin dynamics by impaired mitochondrial respiration.

Authors:  Min Joung Lee; Yunseon Jang; Jeongsu Han; Soo J Kim; Xianshu Ju; Yu Lim Lee; Jianchen Cui; Jiebo Zhu; Min Jeong Ryu; Song-Yi Choi; Woosuk Chung; Chaejeong Heo; Hyon-Seung Yi; Hyun Jin Kim; Yang H Huh; Sookja K Chung; Minho Shong; Gi-Ryang Kweon; Jun Young Heo
Journal:  J Cereb Blood Flow Metab       Date:  2020-01-27       Impact factor: 6.200

Review 6.  The blood-brain barrier.

Authors:  Richard Daneman; Alexandre Prat
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-05       Impact factor: 10.005

Review 7.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

Review 8.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

Review 9.  TREK-king the blood-brain-barrier.

Authors:  Stefan Bittner; Tobias Ruck; Juncal Fernández-Orth; Sven G Meuth
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-21       Impact factor: 4.147

10.  MRI monitoring of monocytes to detect immune stimulating treatment response in brain tumor.

Authors:  Runze Yang; Susobhan Sarkar; Daniel J Korchinski; Ying Wu; V Wee Yong; Jeff F Dunn
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.